| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.851 | 25.672 | 23.372 | 16.727 | 18.604 | 16.713 | 8.221 | 21.864 | 19.340 | 60.180 |
| Total Income - EUR | 21.851 | 25.672 | 23.372 | 16.727 | 18.604 | 16.713 | 8.221 | 21.888 | 19.397 | 60.202 |
| Total Expenses - EUR | 24.468 | 28.445 | 25.023 | 21.225 | 22.684 | 21.412 | 16.552 | 23.740 | 21.963 | 53.677 |
| Gross Profit/Loss - EUR | -2.617 | -2.773 | -1.652 | -4.498 | -4.080 | -4.699 | -8.331 | -1.853 | -2.566 | 6.526 |
| Net Profit/Loss - EUR | -3.272 | -3.286 | -1.885 | -4.666 | -4.213 | -4.811 | -8.414 | -2.072 | -2.761 | 4.720 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Diseasilv Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.091 | 2.244 | 3.169 | 15.118 | 29.174 | 44.335 | 50.622 | 47.669 | 50.762 | 28.900 |
| Inventories | 2.265 | 1.696 | 2.383 | 13.159 | 27.634 | 41.988 | 48.383 | 45.747 | 47.464 | 26.192 |
| Receivables | 134 | 56 | 0 | 113 | 0 | 2 | 348 | 0 | 116 | 109 |
| Cash | 693 | 493 | 786 | 1.846 | 1.540 | 2.345 | 1.891 | 1.922 | 3.182 | 2.599 |
| Shareholders Funds | -35.184 | -38.112 | -39.352 | -43.296 | -46.670 | -50.597 | -57.888 | -60.140 | -62.718 | -57.648 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 38.275 | 40.356 | 42.522 | 58.414 | 75.844 | 94.932 | 108.510 | 107.809 | 113.480 | 86.547 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5630 - 5630" | |||||||||
| CAEN Financial Year |
5630
|
|||||||||
Comments - Diseasilv Srl